Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  934 results for ""OMALIZUMAB""

Your Filters

Subject : anti-asthmatic agents
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Chest CT assess the impact of omalizumab treatment on airway remodeling in refractory asthma.

  • Authors : Shi H; Department of Respiratory and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, China; Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Omalizumab*/Omalizumab*/Omalizumab*/pharmacology ; Asthma*/Asthma*/Asthma*/drug therapy

  • Source: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2024 Dec; Vol. 87, pp. 102329. Date of Electronic Publication: 2024 Oct 03.Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-term use of omalizumab in patients with allergic bronchopulmonary aspergillosis: a tertiary-level care center experience.

  • Authors : Cakmak ME; Department of Allergy and Clinical Immunology, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey.; Öztop N

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Omalizumab*/Omalizumab*/Omalizumab*/administration & dosage ; Aspergillosis, Allergic Bronchopulmonary*/Aspergillosis, Allergic Bronchopulmonary*/Aspergillosis, Allergic Bronchopulmonary*/drug therapy

  • Source: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Dec; Vol. 61 (12), pp. 1663-1671. Date of Electronic Publication: 2024 Jul 08.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8106454 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Model-based comparisons of post-treatment free IgE and FEV1 between omalizumab asthma dosing tables in the United States and European Union.

  • Authors : Zhu R; Genentech, Inc., South San Francisco, California, USA.; Schoemaker R

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/administration & dosage ; Omalizumab*/Omalizumab*/Omalizumab*/pharmacokinetics ; Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Dec; Vol. 90 (12), pp. 3190-3200. Date of Electronic Publication: 2024 Aug 07.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of subcutaneous immunotherapy combined with omalizumab in children with dust mite-induced asthma.

  • Authors : Long C; Department of Pediatrics (III), Linyi People's Hospital, Linyi, Shandong, China.; Sun C

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Omalizumab*/Omalizumab*/Omalizumab*/administration & dosage ; Omalizumab*/Omalizumab*/Omalizumab*/adverse effects

  • Source: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Nov; Vol. 61 (11), pp. 1561-1570. Date of Electronic Publication: 2024 Jul 01.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8106454 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical remission maintained and improved over time in patients with severe asthma treated with omalizumab.

  • Authors : Cilli A; Department of Respiratory Disease, Akdeniz University, Antalya, Türkiye.; Uzer F

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Omalizumab*/Omalizumab*/Omalizumab*/administration & dosage ; Asthma*/Asthma*/Asthma*/drug therapy

  • Source: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2024 Nov; Vol. 61 (11), pp. 1469-1476. Date of Electronic Publication: 2024 Jun 08.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8106454 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic corticosteroid prescriptions: Real-world US ADVANTAGE study.

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Dec; Vol. 154 (6), pp. 1500-1510. Date of Electronic Publication: 2024 Aug 24.Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825

Record details

Read More Add to Saved list
×
Academic Journal

Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications.

  • Authors : Deshmukh AD; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Georgia State University College of Law, Atlanta, Georgia, USA.

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Omalizumab*/Omalizumab*/Omalizumab*/administration & dosage ; Asthma*/Asthma*/Asthma*/drug therapy

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Oct; Vol. 33 (10), pp. e70009.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

Favorable clinical course after discontinuation of omalizumab treatment in patients with allergic severe asthma: A real-world clinical practice.

  • Authors : Hamada S; Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. Electronic address: .; Ogino E

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/administration & dosage ; Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Asthma*/Asthma*/Asthma*/drug therapy

  • Source: Respiratory investigation [Respir Investig] 2024 Sep; Vol. 62 (5), pp. 762-765. Date of Electronic Publication: 2024 Jul 02.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial.

  • Authors : Cornelius V; Health and Social Care Research, Imperial College London, London, UK.; Babalis D

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Anti-Asthmatic Agents*/Anti-Asthmatic Agents*/Anti-Asthmatic Agents*/therapeutic use

  • Source: BMJ open [BMJ Open] 2024 Aug 21; Vol. 14 (8), pp. e090749. Date of Electronic Publication: 2024 Aug 21.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study.

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Asthma*/Asthma*/Asthma*/drug therapy ; Asthma*/Asthma*/Asthma*/blood

  • Source: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 Aug 01; Vol. 210 (3), pp. 288-297.Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  934 results for ""OMALIZUMAB""